The statistic shows the number of employees at pharmaceutical company Pfizer from 2006 to 2024. Pfizer Inc. is a multinational pharmaceutical corporation. The company is headquartered in Midtown Manhattan, New York City. In 2024, Pfizer employed approximately ****** persons around the world. The highest number of employees at Pfizer was reported in 2009, with almost *** thousand employed persons. Pfizer company factsPfizer is a pharmaceutical corporation with its headquarters in New York City, United States. It was founded in **** by Charles Pfizer and Charles Erhart in Brooklyn, New York. Their first product was an antiparasitic called santonin. Currently, Pfizer produces pharmaceutical products for a wide range of medical sectors such as immunology, cardiology, and neurology. Global revenue at Pfizer reached a record-high of over 100 billion U.S. dollars in 2022. Pfizer is active in many countries around the globe. Its research and development activities are focused on the discovery of small molecules as well as large-molecules (biologics), and the development of vaccines. The total number of employees working for Pfizer has decreased from ******* in 2009 to below ****** in 2021. After a merger with Wyeth in 2009, Pfizer cut over ****** employees. Pfizer has been named one of Canada’s top 100 employers by Maclean’s magazine in 2007, but has also been subject to controversy in employment in other countries, like in the United States.

As of May 3, 2022, around 76.6 million Pfizer COVID-19 vaccines had been administered in South Korea. Other major vaccines included Moderna with around 24.5 million doses, and AstraZeneca with around 20.3 million doses. In 2021, the South Korean government announced a COVID-19 vaccination plan for employees under the age of 65 in nursing hospitals or facilities, high-risk medical institutions, and the first responding group including emergency personnel or quarantine personnel, etc. The AstraZeneca vaccine was to be used for this priority group and the vaccination was scheduled to take place from February until May. Furthermore, vaccinations were planned for staff in hospitals treating COVID-19 patients, and the Pfizer vaccine was to be used for this group. South Korea's handling of the coronavirus (COVID-19) was initially widely praised, though the government's handling of vaccine distribution has been criticized.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

As of February 28, 2023, around 79 percent of the Finnish population had received at least one coronavirus (COVID-19) vaccine dose, while 76 percent were vaccinated twice. The region with the highest share of the population vaccinated against COVID-19 nationally was East Savo, followed by South Karelia and South Savo. The highest number of COVID-19 vaccinated people in Finland was recorded in the capital region of Helsinki and Uusimaa.

The coronavirus vaccination rollout started on December 27, 2020 with the BioNTech–Pfizer vaccine. Coronavirus vaccination is offered to everyone aged five or older who is willing to take the vaccine. According to the vaccination order in Finland, COVID-19 vaccinations were first offered to social and healthcare personnel with a higher risk of exposure, risk groups, and those aged 70 years or older.

As of October 27, 2022, around 131.8 million coronavirus (COVID-19) vaccinations were recorded in South Korea. At the beginning of the vaccination campaign, the Korean government announced a COVID-19 vaccination plan for employees under the age of 65 in nursing hospitals or facilities, high-risk medical institutions, and the first responding group including emergency personnel or quarantine personnel, etc. The AstraZeneca vaccine was to be used for this priority group and the vaccination was scheduled to take place from February until May. Furthermore, vaccinations were planned for staff in hospitals treating COVID-19 patients, and the Pfizer vaccine was to be used for this group. South Korea's handling of the coronavirus (COVID-19) was initially widely praised, though the government's handling of vaccine distribution has been criticized.

For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.

By December 6, 2022, over 4.4 million first doses of COVID-19 vaccine and almost 4.3 million second doses have been administered in Finland. The coronavirus vaccination rollout started on December 27, 2020 with the BioNTech–Pfizer vaccine.

Coronavirus vaccination is offered to everyone aged five or older who is willing to take the vaccine. According to the vaccination order in Finland, COVID-19 vaccinations are first offered to social and healthcare personnel with a higher risk of exposure, risk groups, and those aged 70 years and older.

As of December 6, 2022, over 4.5 million first doses of coronavirus (COVID-19) vaccine have been administered in Finland. The highest number of administered vaccine doses were recorded in the capital region of Helsinki and Uusimaa, followed by other populous regions, Pirkanmaa and Varsinais-Suomi. The coronavirus vaccination rollout started on December 27, 2020 with the BioNTech–Pfizer vaccine.

Coronavirus vaccination is offered to everyone aged five or older who is willing to take the vaccine. According to the vaccination order in Finland, COVID-19 vaccinations are first offered to social and healthcare personnel with a higher risk of exposure, risk groups, and those aged 70 years or older.

Since the beginning of the COVID-19 pandemic in the first months of 2020, one of the most anticipated moments was the start of mass immunization against the virus through the administration of vaccines. In December 2020, it was estimated that the number of doses of the Pfizer-BioNTech vaccine required to cover the entire population in Mexico exceeded a total of 250 million. It was estimated that immunizing citizens over 60 would require approximately 31 million doses, while vaccinating all health personnel would require approximately three million.

This statistic shows the 2025 ranking of the top 10 biotech and pharmaceutical companies worldwide, based on net income. U.S.-based company Johnson & Johnson was ranked first with a net income of **** billion U.S. dollars. Biotech and pharmaceutical companiesJohnson & Johnson and Merck & Co., both based in the United States, are among the world’s largest biotechnology and pharmaceutical companies based on their net incomes of approximately **** billion U.S. dollars and **** billion U.S. dollars, respectively, as of 2025. Johnson & Johnson generated some **** billion U.S. dollars of revenue in 2024. Pfizer had record-high annual revenues during the COVID-19 vaccination campaign, exceeding 100 billion U.S. dollars in 2022.

Story of a former blockbuster Lyrica was once one of Pfizer’s most successful products. It is an anticonvulsant for neuropathic pain and is also used as therapy for partial seizures. In the EU and in Russia, Lyrica has also been approved to treat general anxiety disorder. In 2017, this prescription medication generated some **** billion U.S. dollars in revenue.